SCHEMBL2229575

SCHEMBL2229575

N=C(NO)c1ccc(F)c(C(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT5 Q9NXA8 1/20 0.41
HDAC1 Q13547 4/20 0.39
HDAC6 Q9UBN7 4/20 0.39
HDAC8 Q9BY41 2/20 0.39
CES2 O00748 2/20 0.37
CES1 P23141 2/20 0.37
CYP3A4 P08684 1/20 0.37
KDM4E B2RXH2 2/20 0.36
ASPH Q12797 1/20 0.36
KDM8 Q8N371 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25B P30305 1/20 0.36
HSD17B10 Q99714 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
POLB P06746 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTK2B Q14289 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14645588 0.86 EPHX2 (0.43) HDAC1HDAC6HDAC8CES2CES1
SCHEMBL2804263 0.82 ALDH1A1 (0.42) HDAC1HDAC6KDM4EHSD17B10TDP1
SCHEMBL22396417 0.80 AKR1C3 (0.44) HDAC1HDAC6HDAC8CES2KDM4E
SCHEMBL336060 0.79 KDM4E (0.52) SIRT5CES2CES1CYP3A4KDM4E
SCHEMBL30506215 0.77 CES2 (0.50) HDAC1HDAC6CES2CES1RAB9A
SCHEMBL4358318 0.77 TDP1 (0.55) SIRT5CES2CES1CYP3A4KDM4E
SCHEMBL640675 0.77 CES2 (0.50) HDAC1HDAC6CES2CES1RAB9A
SCHEMBL18205175 0.76 LMNA (0.45) HDAC1HDAC6CES2CES1KDM4E
SCHEMBL2226689 0.76 POLB (0.50) HDAC1HDAC6HDAC8KDM4EAKR1C2
SCHEMBL22396389 0.75 ALOX15 (0.42) KDM4EAKR1C2L3MBTL1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704113-B1 BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-10-11 EP disclosed
WO-2011088181-A9 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-31 WO disclosed
EP-2533783-A1 COMPOUNDS AND METHODS Tempero Pharmaceuticals, Inc. (US) 2012-12-19 EP disclosed
WO-2011088181-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2011-07-21 WO disclosed